chr3-119863444-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001146156.2(GSK3B):āc.1071T>Cā(p.Pro357=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00318 in 1,613,898 control chromosomes in the GnomAD database, including 124 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.016 ( 62 hom., cov: 32)
Exomes š: 0.0019 ( 62 hom. )
Consequence
GSK3B
NM_001146156.2 synonymous
NM_001146156.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.29
Genes affected
GSK3B (HGNC:4617): (glycogen synthase kinase 3 beta) The protein encoded by this gene is a serine-threonine kinase belonging to the glycogen synthase kinase subfamily. It is a negative regulator of glucose homeostasis and is involved in energy metabolism, inflammation, ER-stress, mitochondrial dysfunction, and apoptotic pathways. Defects in this gene have been associated with Parkinson disease and Alzheimer disease. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 3-119863444-A-G is Benign according to our data. Variant chr3-119863444-A-G is described in ClinVar as [Benign]. Clinvar id is 784016.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.29 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0532 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GSK3B | NM_001146156.2 | c.1071T>C | p.Pro357= | synonymous_variant | 9/11 | ENST00000264235.13 | |
GSK3B | NM_002093.4 | c.1110T>C | p.Pro370= | synonymous_variant | 10/12 | ||
GSK3B | NM_001354596.2 | c.1071T>C | p.Pro357= | synonymous_variant | 9/10 | ||
GSK3B | XM_006713610.4 | c.1110T>C | p.Pro370= | synonymous_variant | 10/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GSK3B | ENST00000264235.13 | c.1071T>C | p.Pro357= | synonymous_variant | 9/11 | 1 | NM_001146156.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0159 AC: 2413AN: 152176Hom.: 61 Cov.: 32
GnomAD3 genomes
AF:
AC:
2413
AN:
152176
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00457 AC: 1149AN: 251436Hom.: 27 AF XY: 0.00349 AC XY: 474AN XY: 135890
GnomAD3 exomes
AF:
AC:
1149
AN:
251436
Hom.:
AF XY:
AC XY:
474
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00186 AC: 2719AN: 1461604Hom.: 62 Cov.: 30 AF XY: 0.00162 AC XY: 1175AN XY: 727156
GnomAD4 exome
AF:
AC:
2719
AN:
1461604
Hom.:
Cov.:
30
AF XY:
AC XY:
1175
AN XY:
727156
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0159 AC: 2416AN: 152294Hom.: 62 Cov.: 32 AF XY: 0.0151 AC XY: 1128AN XY: 74468
GnomAD4 genome
AF:
AC:
2416
AN:
152294
Hom.:
Cov.:
32
AF XY:
AC XY:
1128
AN XY:
74468
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 21, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 21, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at